Clinical trial
LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures
NCT00144872 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00144872 |
|---|---|
| Title | LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures |
| Official title | Evaluation of Lamotrigine in Subjects With Absence Seizures |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Seizure, Absence |
| Intervention type | Drug |
| Interventions | Lamotrigine |
| Enrollment | 54 |
| Start date | Nov 1, 2004 |
| Primary completion | Apr 22, 2006 |
| Completion | Apr 22, 2006 |
| First posted | Sep 5, 2005 |
| Last update posted | Sep 29, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: